Dr Mahmoud Ghannoum is the Director of the Integrated Microbiome Core and the Center for Medical Mycology at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center. He has been called the leading microbiome researcher in the world; by The Washington Post, and has published over 450 papers on his research on how bacteria and fungi impact our health. His work has been cited over 38,000 times in the scientific literature, and he is the scientist that named the mycobiome, the fungal community in the body. In addition to his research, Dr Ghannoum is the founder of BIOHM, the first company to create probiotics and microbiome tests that address bacteria and fungi in the gut. He is also the founder of DrMicrobiome.com where his team offers personalized coaching programs for optimizing our microbiome. He lives in Cleveland, Ohio.
Dr. Ghannoum just released a peer-reviewed article “A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic” that presents new evidence suggesting organisms found in the gut are critical players in predicting depression and illuminates the link between microbiome health, Covid-19 and depression.
James Lott JR is the host!